Article

A structured review and guide through studies on health-related quality of life in kidney cancer, hepatocellular carcinoma, and leukemia.

Center for Health Economics, Leibniz University Hannover, Hannover, Germany.
Cancer Investigation (impact factor: 1.85). 10/2009; 28(3):312-22. DOI:10.3109/07357900903287022 pp.312-22
Source: PubMed

ABSTRACT Aim of this paper is to review and describe Health-Related Quality of Life (HRQoL) measures applied in kidney cancer, hepatocellular carcinoma, and leukemia patients under drug therapy. A comprehensive search in PubMed was conducted to identify studies assessing quality of life (QoL) in these indications. In total 32 studies, including four studies through reference list checking and 21 different HRQoL instruments, were identified. Six generic, five disease-specific, and 10 domain-specific instruments were identified. In conclusion no overall standards in HRQoL measurement could be observed in the respective indications.

0 0
 · 
0 Bookmarks
 · 
29 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

21 different HRQoL instruments
 
comprehensive search
 
drug therapy
 
generic
 
Health-Related Quality
 
indications
 
kidney cancer
 
leukemia patients
 
reference list checking
 
respective indications
 
standards
 
total 32 studies
 

Jia Liu